Drug Safety Matters

Uppsala Monitoring Centre

5,0 (2)
MÉDECINE
TOUS LES MOIS

Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.

17 DÉC.

#34 Veterinary pharmacovigilance, Part I – James Mount

Human and veterinary pharmacovigilance (PV) share many goals, challenges and approaches. But there are also significant differences, such as the numerous species and breeds that veterinary PV needs to take into account. In this two-part episode of Drug Safety Matters, James Mount, Veterinary Pharmacovigilance assessor at the Swedish Medical Products Agency, and EU elected chair of the Pharmacovigilance Working Party for veterinary medicinal products, joins the show to talk about veterinary PV...

47 min
29 NOV.

#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias

While structured data elements such as patient identifier, medicine name and reaction, are fundamental for adverse event reporting, they may not capture all relevant details. This is where the narrative fields come in, allowing reporters to disclose important contextual information, such as the patient’s full clinical course. But how do PV assessors interact with these narratives in spontaneous reports? What needs and challenges do they experience? These and other questions were addressed in ...

39 min
25 OCT.

#32 Pharmacovigilance in older adults – Giovanni Furlan

Medication-related-harm (MRH) is especially prevalent in older adults due to changing physiology as the body ages, increased frailty, and the incidence of polypharmacy in this patient group. Giovanni Furlan, Worldwide Safety Site Lead for Thessaloniki of Pfizer discusses what makes this patient group so vulnerable to adverse drug reactions, how poor representation and using age alone to define older adults exacerbates this problem, and suggests ways forward in monitoring drug safety in older ...

48 min
30 SEPT.

#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori

Disproportionality analyses are a mainstay of pharmacovigilance research, but without clear guidelines, they often lead to confusion and misinterpretation. Enter the READUS-PV statement: the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible. Tune in to find out: The history of reporting guidelines in pharmacovigilance and why the READUS-PV guidelines were created Why there has been a spike in the publication of dispropor...

43 min
26 AOÛT

Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects

Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here.After the read, we speak to author Jim Barrett, Senior Data Scientist at UMC, to learn more about the duplicate detecti...

25 min
27 JUIN

Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance

Ensuring trust in AI is vital to fully reap the benefits of the technology in pharmacovigilance. Yet, how do we do so while grappling with its ever-growing complexity?This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here.After the read, we speak to one of the authors of the article, Michael Glaser, to learn more about how AI and ML has been used in pharmaco...

30 min
15 MAI

#30 Preventing and reporting medication errors – Rabat CC & UMC

Look-alike medicines, unclear communication and distractions during administration – medication errors may occur for many different reasons. They all have in common that they are unintended mistakes in the drug treatment process that may or may not lead to patient harm. In this episode Ghita Benabdallah and Loubna Alj from the national pharmacovigilance centre of Morocco, and Alem Zekarias from Uppsala Monitoring Centre discuss how we can prevent medication errors from occurring – and, when t...

34 min
23 AVR.

#29 When medicines change our behaviour – Michele Fusaroli

Medicines can affect our personality in positive ways, but they may also lead to destructive behaviours that can damage our relationships, finances, and overall quality of life. Michele Fusaroli from the University of Bologna explains how to diagnose and treat drug-induced impulse control disorders.Tune in to find out:Which medicines may cause impulsivityWhat the ‘four knights’ of impulsivity areHow patient stories can help detect these conditionsWant to know more?This review by Daniel Weintr...

31 min

Tout afficher (51)

5

sur 5

2 notes

Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.

Création

Uppsala Monitoring Centre
Années d’activité

2020 - 2024
Épisodes

51
Classification

Tous publics
Site web de l’émission

Drug Safety Matters

Forme et santé

Forme et santé

Chaque semaine
Science de la vie

Science de la vie

Toutes les 2 semaines
Forme et santé

Forme et santé

Tous les jours
Entreprenariat

Entreprenariat

Toutes les 2 semaines
Médecine parallèle

Médecine parallèle

Deux fois par semaine
Technologies

Technologies

Deux fois par mois
Médecine

Médecine

Chaque semaine

Drug Safety Matters

#34 Veterinary pharmacovigilance, Part I – James Mount

#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias

#32 Pharmacovigilance in older adults – Giovanni Furlan

#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori

Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects

Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance

#30 Preventing and reporting medication errors – Rabat CC & UMC

#29 When medicines change our behaviour – Michele Fusaroli

Notes et avis

À propos

Informations

Vous aimeriez peut‑être aussi

Drug Safety Matters

Épisodes

#34 Veterinary pharmacovigilance, Part I – James Mount

#33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias

#32 Pharmacovigilance in older adults – Giovanni Furlan

#31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori

Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects

Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance

#30 Preventing and reporting medication errors – Rabat CC & UMC

#29 When medicines change our behaviour – Michele Fusaroli

Notes et avis

À propos

Informations

Vous aimeriez peut‑être aussi